Tumour-infiltrating NK cells and γδ T-cells for cellular immunotherapy
The frequent downregulation or complete loss of major histocompatibility complex (MHC) expression by tumour cells often compromises patients’ response to standard cancer treatments or αβ T-cell-based therapies. Thus, NK cell and ɣδ T-cell-based cancer immunotherapies emerged as complementary treatme...
Autor principal: | |
---|---|
Formato: | masterThesis |
Idioma: | eng |
Publicado em: |
2021
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10362/112051 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/112051 |